CARA extension of DME

The contract involves the extension of the CARA development, modernization, and enhancement (DME) project, specifically focusing on the second phase aimed at the autopopulation of CDC and Samples data. This initiative is under the Food and Drug Administration (FDA) and falls within the NAICS code 541990, which typically relates to professional, scientific, and technical services. The contract is currently in a forecast stage, indicating that it is an expected future procurement, with no solicitation number assigned yet. Key points include the focus on leveraging technology to improve data handling related to CDC and sample populations, which likely aims to increase efficiency and accuracy in data management for the agency. While specific location details for performance are not provided, the contract highlights primary contacts for acquisition and contracting within the FDA, ensuring points of communication for interested parties. The opportunity is publicly accessible via the industry forecast link provided by the FDA’s Office of Small and Disadvantaged Business Utilization.